Macrogenics (MGNX) Tops Q2 EPS by 19c

Macrogenics (NASDAQ: MGNX) reported Q2 EPS of ($1.03), $0.19 better than the analyst estimate of ($1.22). Revenue for the quarter came in at $18.8 million versus the consensus estimate of $4.21 million.

For earnings history and earnings-related data on Macrogenics (MGNX) click here.

You May Also Be Interested In

• Macrogenics (MGNX) Misses Q2 EPS by 102c
• Laird Superfood, Inc. (LSF) Misses Q2 EPS by 22c ; Offers Guidance
• CaliberCos Inc (CWD) Misses Q2 EPS by 43c; Offers Guidance